Enantioselective reduction of beta-ketophosphonates 1a-b by Saccharomyces cerevisiae afforded building blocks for the stereoselective syntheses of fosfomycin, an important pharmaceutical compound, isolated in excellent yield (89-92%).
Introduction
Optically active beta-hydroxyalkanephosphonic acid derivatives are important precursors for pharmaceuticals compounds 1 and fosfomycin, Figure 1 , is an antibiotic used as an effective treatment for urinary tract infections, particularly since it is highly effective when applied as a single dose. In this work, we report the preliminary enantioselective bioreduction of betaketophosphonates 1a-b using whole cells of Saccharomyces cerevisiae in excellent yield. Compound 2b will be used to prepare fosfomycin.
Results and Discussion
The beta-ketophosphonate 1a was synthesized using chloroacetone, trimethylphosphite and potassium iodide in dichloromethane at room temperature 3 ; and beta-ketophosphonates 1b by chlorination of 1a using HCl 2N and oxone® in dichloromethane at room temperature 4 . Enantioselective reduction of compounds 1a-b mediated by Saccharomyces cerevisiae, Figure 2 , provided the beta-hydroxy phosphonates 2a-b in excellent yields, Table 1 . 
Conclusions
The enantioselective reduction betaketophosphonates 1a-b mediated by Saccharomyces cerevisiae provided corresponding alcohols in excellent isolated yields. Studies are been conducted to determine the enantiomeric excess (ee) of beta-hydroxy phosphonates 2a-b and absolute configuration of 2b.
